Bonnie Teng

Bonnie joined the Melanoma Research Foundation (MRF) as the Chief Scientific Officer in February 2025. In this role, she leads the foundation’s scientific direction and manages its research grant programs. Bonnie has over 20 years of experience in basic science and translational research, including 15 years in the oncology field. Prior to joining the MRF, she was a Senior Scientist at the Women’s Health Integrated Research Center of the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF). With the goal of advancing cancer diagnosis and treatment, she led research projects on cancer biology, tumor microenvironment and drug target discovery using genomic and proteomic strategies. In addition to studying disease progression, she developed cell models for cancer drug testing and created online tools for proteomic data analysis. Bonnie completed two postdoctoral fellowships in the Department of Pharmacology and Chemical Biology at the University of Pittsburgh and at HJF. During her fellowships, she conducted research on biomarker discovery and cancer drug resistance. She earned her PhD and Master's degree in Bioengineering from the University of Pittsburgh. She has a Bachelor’s degree in Biomedical Engineering from Washington University in St. Louis. Bonnie is passionate about the MRF’s mission and deeply committed to supporting the melanoma community. In her spare time, she enjoys baking and spending time with her family.